XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
DeepHealth, Inc.
Total Radnet, Inc.'s Equity
Common Stock
Common Stock
DeepHealth, Inc.
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2021       53,548,227          
Beginning balance at Dec. 31, 2021 $ 346,157   $ 228,904 $ 5   $ 342,592 $ (20,421) $ (93,272) $ 117,253
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under the equity compensation plan (in shares)       530,188 13,119        
Stock-based compensation expense 10,801   10,801     10,801      
Issuance of common stock for acquisitions (in shares)       2,106,292          
Issuance of common stock for acquisitions 56,470   56,470     56,470      
Change in cumulative foreign currency translation adjustment (1,264)   (1,264)       (1,264)    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 923   923       923    
Other 0   0       1 (1)  
Net (loss) income 8,363   3,013         3,013 5,350
Ending balance (in shares) at Mar. 31, 2022       56,197,826          
Ending balance at Mar. 31, 2022 $ 421,450   298,847 $ 5   409,863 (20,761) (90,260) 122,603
Beginning balance (in shares) at Dec. 31, 2022 57,723,125     57,723,125          
Beginning balance at Dec. 31, 2022 $ 491,452   332,995 $ 6   436,288 (20,677) (82,622) 158,457
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon exercise of options (in shares) 5,000 14,473   5,000          
Issuance of common stock upon exercise of options $ 51   51     51      
Issuance of common stock under the equity compensation plan (in shares)       527,692 14,473        
Stock-based compensation expense 12,185   12,185     12,185      
Change in cumulative foreign currency translation adjustment 2,777   2,777       2,777    
Change in fair value of cash flow hedge from prior periods reclassified to earnings, net of taxes 922   922       922    
Other (3)   (3)     (2)   (1)  
Net (loss) income $ (14,283)   (21,005)         (21,005) 6,722
Ending balance (in shares) at Mar. 31, 2023 58,270,290     58,270,290          
Ending balance at Mar. 31, 2023 $ 493,101   $ 327,922 $ 6   $ 448,522 $ (16,978) $ (103,628) $ 165,179